[HTML][HTML] Human adipose-derived mesenchymal stem cells attenuate early stage of bleomycin induced pulmonary fibrosis: comparison with pirfenidone
M Reddy, L Fonseca, S Gowda… - … journal of stem cells - synapse.koreamed.org
Methods Human AD-MSCs were administered intravenously on day 3, 6 and 9 after an intra-
tracheal challenge with bleomycin, whereas, pirfenidone was given orally in drinking water …
tracheal challenge with bleomycin, whereas, pirfenidone was given orally in drinking water …
[PDF][PDF] Human Adipose-derived Mesenchymal Stem Cells Attenuate Early Stage of Bleomycin Induced Pulmonary Fibrosis: Comparison with Pirfenidone
M Reddy, L Fonseca, S Gowda, B Chougule, A Hari… - scienceopen.com
Methods: Human AD-MSCs were administered intravenously on day 3, 6 and 9 after an intra-
tracheal challenge with bleomycin, whereas, pirfenidone was given orally in drinking water …
tracheal challenge with bleomycin, whereas, pirfenidone was given orally in drinking water …
[HTML][HTML] Human Adipose-derived Mesenchymal Stem Cells Attenuate Early Stage of Bleomycin Induced Pulmonary Fibrosis: Comparison with Pirfenidone
M Reddy, L Fonseca, S Gowda… - … Journal of Stem Cells, 2016 - ncbi.nlm.nih.gov
Methods Human AD-MSCs were administered intravenously on day 3, 6 and 9 after an intra-
tracheal challenge with bleomycin, whereas, pirfenidone was given orally in drinking water …
tracheal challenge with bleomycin, whereas, pirfenidone was given orally in drinking water …
Human Adipose-derived Mesenchymal Stem Cells Attenuate Early Stage of Bleomycin Induced Pulmonary Fibrosis: Comparison with Pirfenidone
M Reddy, L Fonseca, S Gowda… - … Journal of Stem …, 2016 - oldkmbase.medric.or.kr
Abstract Background and Objectives: Idiopathic pulmonary fibrosis (IPF) is a progressive,
irreversible, invariably fatal fibrotic lung disease with no lasting option for therapy …
irreversible, invariably fatal fibrotic lung disease with no lasting option for therapy …
Human Adipose-derived Mesenchymal Stem Cells Attenuate Early Stage of Bleomycin Induced Pulmonary Fibrosis: Comparison with Pirfenidone
M REDDY, L FONSECA, S GOWDA… - … Journal of Stem …, 2016 - pesquisa.bvsalud.org
OBJECTIVES: Idiopathic pulmonary fibrosis (IPF) is a progressive, irreversible, invariably
fatal fibrotic lung disease with no lasting option for therapy. Mesenchymal stem cells (MSCs) …
fatal fibrotic lung disease with no lasting option for therapy. Mesenchymal stem cells (MSCs) …
Human Adipose-derived Mesenchymal Stem Cells Attenuate Early Stage of Bleomycin Induced Pulmonary Fibrosis: Comparison with Pirfenidone
M Reddy, L Fonseca, S Gowda… - … journal of stem …, 2016 - pubmed.ncbi.nlm.nih.gov
Background and objectives Idiopathic pulmonary fibrosis (IPF) is a progressive, irreversible,
invariably fatal fibrotic lung disease with no lasting option for therapy. Mesenchymal stem …
invariably fatal fibrotic lung disease with no lasting option for therapy. Mesenchymal stem …
[引用][C] Human Adipose-derived Mesenchymal Stem Cells Attenuate Early Stage of Bleomycin Induced Pulmonary Fibrosis: Comparison with Pirfenidone
M Reddy, L Fonseca, S Gowda, B Chougule… - International Journal of …, 2016 - cir.nii.ac.jp
Human Adipose-derived Mesenchymal Stem Cells Attenuate Early Stage of Bleomycin Induced
Pulmonary Fibrosis: Comparison with Pirfenidone | CiNii Research CiNii 国立情報学研究所 学術 …
Pulmonary Fibrosis: Comparison with Pirfenidone | CiNii Research CiNii 国立情報学研究所 学術 …
Human Adipose-derived Mesenchymal Stem Cells Attenuate Early Stage of Bleomycin Induced Pulmonary Fibrosis: Comparison with Pirfenidone.
M Reddy, L Fonseca, S Gowda… - … Journal of Stem Cells, 2016 - europepmc.org
Methods Human AD-MSCs were administered intravenously on day 3, 6 and 9 after an intra-
tracheal challenge with bleomycin, whereas, pirfenidone was given orally in drinking water …
tracheal challenge with bleomycin, whereas, pirfenidone was given orally in drinking water …
Human Adipose-derived Mesenchymal Stem Cells Attenuate Early Stage of Bleomycin Induced Pulmonary Fibrosis: Comparison with Pirfenidone
M Reddy, L Fonseca, S Gowda, B Chougule, A Hari… - International Journal of … - KoreaMed
METHODS Human AD-MSCs were administered intravenously on day 3, 6 and 9 after an
intra-tracheal challenge with bleomycin, whereas, pirfenidone was given orally in drinking …
intra-tracheal challenge with bleomycin, whereas, pirfenidone was given orally in drinking …
[HTML][HTML] Human Adipose-derived Mesenchymal Stem Cells Attenuate Early Stage of Bleomycin Induced Pulmonary Fibrosis: Comparison with Pirfenidone
M Reddy, L Fonseca, S Gowda, B Chougule… - International Journal of …, 2016 - ijstemcell.com
Methods Human AD-MSCs were administered intravenously on day 3, 6 and 9 after an intra-
tracheal challenge with bleomycin, whereas, pirfenidone was given orally in drinking water …
tracheal challenge with bleomycin, whereas, pirfenidone was given orally in drinking water …